Fathi I, Sakr M (2014) Review of tumoral calcinosis: a rare clinico-pathological entity. World J Clin Cases 2(9):409–414
Article PubMed PubMed Central Google Scholar
Boyce AM, Lee AE, Roszko KL, Gafni RI (2020) Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management. Front Endocrinol (Lausanne) 11:293
Ito N, Fukumoto S (2021) Congenital hyperphosphatemic conditions caused by the deficient activity of FGF23. Calcif Tissue Int 108(1):104–115
Article CAS PubMed Google Scholar
Chefetz I, Ben Amitai D, Browning S, Skorecki K, Adir N, Thomas MG et al (2008) Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein. J Invest Dermatol 128(6):1423–1429
Article CAS PubMed Google Scholar
Olsen KM, Chew FS (2006) Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics 26(3):871–885
Ramnitz MS, Gafni RI, Collins MT (1993) Hyperphosphatemic Familial Tumoral Calcinosis. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle. http://www.ncbi.nlm.nih.gov/books/NBK476672/. Accessed 1 Dec 2023
Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23(2):60–63
Article PubMed PubMed Central Google Scholar
Evans JM, Roberts CC, Lidner TK (2008) Tumoral calcinosis causing bilateral thigh pain. Radiol Case Rep 3(2):206
Tiwari V, Zahra F (2023) Hyperphosphatemic tumoral calcinosis. In: StatPearls. StatPearls Publishing, Treasure Island (FL)
Lingappa L, Ichikawa S, Gray A, Acton D, Evans M, Madarasu R et al (2019) An unusual combination of neurological manifestations and sudden vision loss in a child with familial hyperphosphatemic tumoral calcinosis. Ann Indian Acad Neurol 22(3):327–331
Article PubMed PubMed Central Google Scholar
Ahmed S, Saeed A, Farooq S, Yaqoob Z, Zohra FT, Waqas M (2022) Long follow-up of multiple recurrent calcific masses—a rare case report of hyperphosphatemic familial tumoral calcinosis. J Univ Med Dental Coll 13(2):399–402
Alves C, Lima R (2011) Hyperphosphatemic tumoral calcinosis: a 10-year follow-up. J Pediatr Endocrinol Metab 24(1–2):25–27
Balachandran K, Kamalanathan S, Sahoo JP, Das AK, Halanaik D (2014) Differential response of idiopathic sporadic tumoral calcinosis to bisphosphonates. Indian J Endocrinol Metab 18(4):521–525
Article CAS PubMed PubMed Central Google Scholar
Baldursson H, Evans EB, Dodge WF, Jackson WT (1969) Tumoral calcinosis with hyperphosphatemia. A report of a family with incidence in four siblings. J Bone Joint Surg Am 51(5):913–925
Article CAS PubMed Google Scholar
Blay P, Fernández-Martínez JM, Díaz-López B (2001) Vertebral involvement in hyperphosphatemic tumoral calcinosis. Bone 28(3):316–318
Article CAS PubMed Google Scholar
Boal RL, Starzyk B, Coles J, Owen C, Tse Y (2020) Hyperphosphatemic familial tumoral calcinosis complicated by pica. Arch Dis Child. Sep 25;archdischild-2020–319941.
Carmichael KD, Bynum JA, Evans EB (2009) Familial tumoral calcinosis: a forty-year follow-up on one family. J Bone Joint Surg Am 91(3):664–671
Chakhtoura M, Ramnitz MS, Khoury N, Nemer G, Shabb N, Abchee A et al (2018) Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature. Osteoporos Int 29(9):1987–2009
Article CAS PubMed Google Scholar
Chausmer A, Meyer W, Prince M (1982) Phosphate depletion therapy in two ectopic calcification syndromes. J Am Coll Nutr 1(3):275–283
Article CAS PubMed Google Scholar
Claramunt-Taberner D, Bertholet-Thomas A, Carlier MC, Dijoud F, Chotel F, Silve C et al (2018) Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia? Pediatr Nephrol 33(7):1263–1267
Clarke E, Swischuk LE, Hayden CK Jr (1984) Tumoral calcinosis, diaphysitis, and hyperphosphatemia. Radiology 151(3):643–646
Article CAS PubMed Google Scholar
Dauchez A, Souffir C, Quartier P, Baujat G, Briot K, Roux C. Hyperphosphatemic familial tumoral calcinosis with Galnt3 Mutation: transient response to anti-interleukin-1 treatments. JBMR Plus [Internet]. 2019;3(7). https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085067248&doi=10.1002%2fjbm4.10185&partnerID=40&md5=58112f56021e5f2d5c8fb0a89839fb03
Döneray H, Özden A, Gürbüz K (2022) The successful treatment of deep soft-tissue calcifications with topical sodium thiosulphate and acetazolamide in a boy with hyperphosphatemic familial tumoral calcinosis due to a novel mutation in FGF23. JCRPE J Clin Res Pediatr Endocrinol 14(2):239–243
Finer G, Price HE, Shore RM, White KE, Langman CB (2014) Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms. Am J Med Genet A 164A(6):1545–1549
Freedman JD, Novak R, Bratman Morag S, Avitan-Hersh E, Nikomarov D (2021) Bone involvement in hyperphosphatemic familial tumoral calcinosis: a new phenotypic presentation. Rambam Maimonides Med J 12(3).
Goldenstein PT, Neves PD, Balbo BE, Elias RM, Pereira AC, Onuchic LF et al (2018) Dialysis as a treatment option for a patient with normal kidney function and familial tumoral calcinosis due to a compound heterozygous FGF23 mutation. Am J Kidney Dis 72(3):457–461
Article PubMed PubMed Central Google Scholar
Guerra MG, Videira T, de Fonseca D, Vieira R, Dos Santos J, Pinto S (2020) Hyperphosphataemic familial tumoral calcinosis: case report of a rare and challenging disease. Scand J Rheumatol 49(1):80–81
Article CAS PubMed Google Scholar
Huang J, Cao LG, Zhang TR, Li SM, Meng QQ (2022) Primary hyperphosphatemic tumoral calcinosis: a case report. Osteoporos Int 33(1):309–312
Article CAS PubMed Google Scholar
Ichikawa S, Baujat G, Seyahi A, Garoufali AG, Imel EA, Padgett LR et al (2010) Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations. Am J Med Genet A 152(4):896–903
Jost J, Bahans C, Courbebaisse M, Tran TA, Linglart A, Benistan K et al (2016) Topical sodium thiosulfate: a treatment for calcifications in hyperphosphatemic familial tumoral calcinosis? J Clin Endocrinol Metab 101(7):2810–2815
Article CAS PubMed Google Scholar
Keskar VS, Imel EA, Kulkarni M, Mane S, Jamale TE, Econs MJ et al (2015) The case|ectopic calcifications in a child. Kidney Int 87(5):1079–1081
Article PubMed PubMed Central Google Scholar
Lammoglia JJ, Mericq V (2009) Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. Horm Res 71(3):178–184
Lee AE, Hartley IR, Roszko KL, Vanek C, Gafni RI, Collins MT. Hyperphosphatemic familial tumoral calcinosis hidden in plain sight for 73 years: a case report. frontiers in dental medicine [Internet]. 2021;2. https://www.scopus.com/inward/record.uri?eid=2-s2.0-85158968520&doi=10.3389%2ffdmed.2021.719752&partnerID=40&md5=35f833f2789c4c6d991ef8488eff8779
Li WX, Stanek J (2023) Hyperphosphatemic familial tumoral calcinosis in a dancer. PM and R 15(5):685–687
Lufkin EG, Kumar R, Heath H 3rd (1983) Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action. J Clin Endocrinol Metab 56(6):1319–1322
Article CAS PubMed Google Scholar
Mahjoubi F, Ghadir M, Samanian S, Heydari I, Honardoost M (2020) Hyperphosphatemic familial tumoral calcinosis caused by a novel variant in the GALNT3 gene. J Endocrinol Invest 43(8):1125–1130
Article CAS PubMed Google Scholar
Mallick S, Ahmad Z, Gupta AK, Mathur SR (2013) Hyperphosphatemic tumoral calcinosis. BMJ Case Rep [Internet]. https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878666936&doi=10.1136%2fbcr-2013-008728&partnerID=40&md5=e6e93f158ac4fcb4283845874516f5fb
留言 (0)